Sify Technologies Faces Nasdaq Non-Compliance After Director Resignation—Cure Period in Place!

Unknown Apr 02, 2026 1,050 Views

Sify Technologies Ltd. has notified Nasdaq of its noncompliance with listing requirements, following the resignation of Dr. Ajay Kumar from its Board of Directors. The company now falls short of independent director and audit committee requirements, triggering a cure period to regain compliance....